(2R)-3-[4-[6-amino-1-[4-(2-fluorophenoxy)cyclohexyl]pyrazolo[4,3-c]pyridin-3-yl]pyrazol-1-yl]propane-1,2-diol;1-[4-(2,3-difluorophenoxy)cyclohexyl]-3-(1-methylpyrazol-4-yl)-N-phenylpyrazolo[4,3-c]pyridin-6-amine;N-ethyl-1-[4-(2-fluorophenoxy)cyclohexyl]-3-(4-methylimidazol-1-yl)pyrazolo[4,3-c]pyridin-6-amine;N-ethyl-1-[4-(2-fluorophenoxy)cyclohexyl]-3-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrazolo[4,3-c]pyridin-6-amine;2-methyl-6-[4-[5-(methylamino)-1-(1-methylpyrazol-4-yl)pyrazolo[3,4-c]pyridin-3-yl]cyclohexyl]oxypyridazin-3-one

C130H145F5N32O8 — CID 163419657

IUPAC(2R)-3-[4-[6-amino-1-[4-(2-fluorophenoxy)cyclohexyl]pyrazolo[4,3-c]pyridin-3-yl]pyrazol-1-yl]propane-1,2-diol;1-[4-(2,3-difluorophenoxy)cyclohexyl]-3-(1-methylpyrazol-4-yl)-N-phenylpyrazolo[4,3-c]pyridin-6-amine;N-ethyl-1-[4-(2-fluorophenoxy)cyclohexyl]-3-(4-methylimidazol-1-yl)pyrazolo[4,3-c]pyridin-6-amine;N-ethyl-1-[4-(2-fluorophenoxy)cyclohexyl]-3-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrazolo[4,3-c]pyridin-6-amine;2-methyl-6-[4-[5-(methylamino)-1-(1-methylpyrazol-4-yl)pyrazolo[3,4-c]pyridin-3-yl]cyclohexyl]oxypyridazin-3-one
SMILESCCNc1cc2c(cn1)c(-c1ccc(CN3CCN(C)CC3)cc1)nn2C1CCC(Oc2ccccc2F)CC1.CCNc1cc2c(cn1)c(-n1cnc(C)c1)nn2C1CCC(Oc2ccccc2F)CC1.CNc1cc2c(C3CCC(Oc4ccc(=O)n(C)n4)CC3)nn(-c3cnn(C)c3)c2cn1.Cn1cc(-c2nn(C3CCC(Oc4cccc(F)c4F)CC3)c3cc(Nc4ccccc4)ncc23)cn1.Nc1cc2c(cn1)c(-c1cnn(C[C@@H](O)CO)c1)nn2C1CCC(Oc2ccccc2F)CC1
InChIInChI=1S/C32H39FN6O.C28H26F2N6O.C24H27FN6O3.C24H27FN6O.C22H26N8O2/c1-3-34-31-20-29-27(21-35-31)32(24-10-8-23(9-11-24)22-38-18-16-37(2)17-19-38)36-39(29)25-12-14-26(15-13-25)40-30-7-5-4-6-28(30)33;1-35-17-18(15-32-35)28-22-16-31-26(33-19-6-3-2-4-7-19)14-24(22)36(34-28)20-10-12-21(13-11-20)37-25-9-5-8-23(29)27(25)30;25-20-3-1-2-4-22(20)34-18-7-5-16(6-8-18)31-21-9-23(26)27-11-19(21)24(29-31)15-10-28-30(12-15)13-17(33)14-32;1-3-26-23-12-21-19(13-27-23)24(30-14-16(2)28-15-30)29-31(21)17-8-10-18(11-9-17)32-22-7-5-4-6-20(22)25;1-23-19-10-17-18(12-24-19)30(15-11-25-28(2)13-15)27-22(17)14-4-6-16(7-5-14)32-20-8-9-21(31)29(3)26-20/h4-11,20-21,25-26H,3,12-19,22H2,1-2H3,(H,34,35);2-9,14-17,20-21H,10-13H2,1H3,(H,31,33);1-4,9-12,16-18,32-33H,5-8,13-14H2,(H2,26,27);4-7,12-15,17-18H,3,8-11H2,1-2H3,(H,26,27);8-14,16H,4-7H2,1-3H3,(H,23,24)/t;;16?,17-,18?;;/m..1../s1
InChIKeyAHIYLGOZTPOIAW-REQHRXTNSA-N
MW2378.80 g/mol
LogP22.78
Rot. Bonds32

About (2R)-3-[4-[6-amino-1-[4-(2-fluorophenoxy)cyclohexyl]pyrazolo[4,3-c]pyridin-3-yl]pyrazol-1-yl]propane-1,2-diol;1-[4-(2,3-difluorophenoxy)cyclohexyl]-3-(1-methylpyrazol-4-yl)-N-phenylpyrazolo[4,3-c]pyridin-6-amine;N-ethyl-1-[4-(2-fluorophenoxy)cyclohexyl]-3-(4-methylimidazol-1-yl)pyrazolo[4,3-c]pyridin-6-amine;N-ethyl-1-[4-(2-fluorophenoxy)cyclohexyl]-3-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrazolo[4,3-c]pyridin-6-amine;2-methyl-6-[4-[5-(methylamino)-1-(1-methylpyrazol-4-yl)pyrazolo[3,4-c]pyridin-3-yl]cyclohexyl]oxypyridazin-3-one

(2R)-3-[4-[6-amino-1-[4-(2-fluorophenoxy)cyclohexyl]pyrazolo[4,3-c]pyridin-3-yl]pyrazol-1-yl]propane-1,2-diol;1-[4-(2,3-difluorophenoxy)cyclohexyl]-3-(1-methylpyrazol-4-yl)-N-phenylpyrazolo[4,3-c]pyridin-6-amine;N-ethyl-1-[4-(2-fluorophenoxy)cyclohexyl]-3-(4-methylimidazol-1-yl)pyrazolo[4,3-c]pyridin-6-amine;N-ethyl-1-[4-(2-fluorophenoxy)cyclohexyl]-3-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrazolo[4,3-c]pyridin-6-amine;2-methyl-6-[4-[5-(methylamino)-1-(1-methylpyrazol-4-yl)pyrazolo[3,4-c]pyridin-3-yl]cyclohexyl]oxypyridazin-3-one (PubChem CID 163419657) has the molecular formula C130H145F5N32O8 and a molecular weight of 2378.80 g/mol. Its IUPAC name is (2R)-3-[4-[6-amino-1-[4-(2-fluorophenoxy)cyclohexyl]pyrazolo[4,3-c]pyridin-3-yl]pyrazol-1-yl]propane-1,2-diol;1-[4-(2,3-difluorophenoxy)cyclohexyl]-3-(1-methylpyrazol-4-yl)-N-phenylpyrazolo[4,3-c]pyridin-6-amine;N-ethyl-1-[4-(2-fluorophenoxy)cyclohexyl]-3-(4-methylimidazol-1-yl)pyrazolo[4,3-c]pyridin-6-amine;N-ethyl-1-[4-(2-fluorophenoxy)cyclohexyl]-3-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrazolo[4,3-c]pyridin-6-amine;2-methyl-6-[4-[5-(methylamino)-1-(1-methylpyrazol-4-yl)pyrazolo[3,4-c]pyridin-3-yl]cyclohexyl]oxypyridazin-3-one.

Molecular Properties

Compound Name(2R)-3-[4-[6-amino-1-[4-(2-fluorophenoxy)cyclohexyl]pyrazolo[4,3-c]pyridin-3-yl]pyrazol-1-yl]propane-1,2-diol;1-[4-(2,3-difluorophenoxy)cyclohexyl]-3-(1-methylpyrazol-4-yl)-N-phenylpyrazolo[4,3-c]pyridin-6-amine;N-ethyl-1-[4-(2-fluorophenoxy)cyclohexyl]-3-(4-methylimidazol-1-yl)pyrazolo[4,3-c]pyridin-6-amine;N-ethyl-1-[4-(2-fluorophenoxy)cyclohexyl]-3-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrazolo[4,3-c]pyridin-6-amine;2-methyl-6-[4-[5-(methylamino)-1-(1-methylpyrazol-4-yl)pyrazolo[3,4-c]pyridin-3-yl]cyclohexyl]oxypyridazin-3-one
PubChem CID163419657
Molecular FormulaC130H145F5N32O8
Molecular Weight2378.80 g/mol
Exact Mass2377.18
IUPAC Name(2R)-3-[4-[6-amino-1-[4-(2-fluorophenoxy)cyclohexyl]pyrazolo[4,3-c]pyridin-3-yl]pyrazol-1-yl]propane-1,2-diol;1-[4-(2,3-difluorophenoxy)cyclohexyl]-3-(1-methylpyrazol-4-yl)-N-phenylpyrazolo[4,3-c]pyridin-6-amine;N-ethyl-1-[4-(2-fluorophenoxy)cyclohexyl]-3-(4-methylimidazol-1-yl)pyrazolo[4,3-c]pyridin-6-amine;N-ethyl-1-[4-(2-fluorophenoxy)cyclohexyl]-3-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrazolo[4,3-c]pyridin-6-amine;2-methyl-6-[4-[5-(methylamino)-1-(1-methylpyrazol-4-yl)pyrazolo[3,4-c]pyridin-3-yl]cyclohexyl]oxypyridazin-3-one
SMILESCCNc1cc2c(cn1)c(-c1ccc(CN3CCN(C)CC3)cc1)nn2C1CCC(Oc2ccccc2F)CC1.CCNc1cc2c(cn1)c(-n1cnc(C)c1)nn2C1CCC(Oc2ccccc2F)CC1.CNc1cc2c(C3CCC(Oc4ccc(=O)n(C)n4)CC3)nn(-c3cnn(C)c3)c2cn1.Cn1cc(-c2nn(C3CCC(Oc4cccc(F)c4F)CC3)c3cc(Nc4ccccc4)ncc23)cn1.Nc1cc2c(cn1)c(-c1cnn(C[C@@H](O)CO)c1)nn2C1CCC(Oc2ccccc2F)CC1
InChIInChI=1S/C32H39FN6O.C28H26F2N6O.C24H27FN6O3.C24H27FN6O.C22H26N8O2/c1-3-34-31-20-29-27(21-35-31)32(24-10-8-23(9-11-24)22-38-18-16-37(2)17-19-38)36-39(29)25-12-14-26(15-13-25)40-30-7-5-4-6-28(30)33;1-35-17-18(15-32-35)28-22-16-31-26(33-19-6-3-2-4-7-19)14-24(22)36(34-28)20-10-12-21(13-11-20)37-25-9-5-8-23(29)27(25)30;25-20-3-1-2-4-22(20)34-18-7-5-16(6-8-18)31-21-9-23(26)27-11-19(21)24(29-31)15-10-28-30(12-15)13-17(33)14-32;1-3-26-23-12-21-19(13-27-23)24(30-14-16(2)28-15-30)29-31(21)17-8-10-18(11-9-17)32-22-7-5-4-6-20(22)25;1-23-19-10-17-18(12-24-19)30(15-11-25-28(2)13-15)27-22(17)14-4-6-16(7-5-14)32-20-8-9-21(31)29(3)26-20/h4-11,20-21,25-26H,3,12-19,22H2,1-2H3,(H,34,35);2-9,14-17,20-21H,10-13H2,1H3,(H,31,33);1-4,9-12,16-18,32-33H,5-8,13-14H2,(H2,26,27);4-7,12-15,17-18H,3,8-11H2,1-2H3,(H,26,27);8-14,16H,4-7H2,1-3H3,(H,23,24)/t;;16?,17-,18?;;/m..1../s1
InChIKeyAHIYLGOZTPOIAW-REQHRXTNSA-N
XLogP22.78
TPSA426.95 Ų
H-Bond Donors7
H-Bond Acceptors40
Rotatable Bonds32
Heavy Atoms175
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002378.80
LogP ≤ 522.78
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1040

Analyze (2R)-3-[4-[6-amino-1-[4-(2-fluorophenoxy)cyclohexyl]pyrazolo[4,3-c]pyridin-3-yl]pyrazol-1-yl]propane-1,2-diol;1-[4-(2,3-difluorophenoxy)cyclohexyl]-3-(1-methylpyrazol-4-yl)-N-phenylpyrazolo[4,3-c]pyridin-6-amine;N-ethyl-1-[4-(2-fluorophenoxy)cyclohexyl]-3-(4-methylimidazol-1-yl)pyrazolo[4,3-c]pyridin-6-amine;N-ethyl-1-[4-(2-fluorophenoxy)cyclohexyl]-3-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrazolo[4,3-c]pyridin-6-amine;2-methyl-6-[4-[5-(methylamino)-1-(1-methylpyrazol-4-yl)pyrazolo[3,4-c]pyridin-3-yl]cyclohexyl]oxypyridazin-3-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

6-[4-[3-[1-[(2R)-2,3-dihydroxypropyl]pyrazol-4-yl]-6-(ethylamino)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-ethylpyridazin-3-one;6-[4-[3-[1-[(2R)-2,3-dihydroxypropyl]pyrazol-4-yl]-6-(ethylamino)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;6-[4-[6-(ethylamino)-3-[4-[(3-fluoroazetidin-1-yl)methyl]phenyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;2-ethyl-6-[4-[6-(ethylamino)-3-[6-[(4-methylpiperazin-1-yl)methyl]-3-pyridinyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxypyridazin-3-one
CID 163929705
(2R)-3-[4-[1-[4-(2,4-difluorophenoxy)cyclohexyl]-6-(ethylamino)pyrazolo[4,3-c]pyridin-3-yl]pyrazol-1-yl]propane-1,2-diol
CID 138715626
(2R)-3-[4-[1-[4-(2,4-dimethylpyrimidin-5-yl)oxycyclohexyl]-6-(ethylamino)pyrazolo[4,3-c]pyridin-3-yl]pyrazol-1-yl]propane-1,2-diol
CID 138715012
(2R)-3-[4-[6-(ethylamino)-1-[4-(2-fluoro-3-isocyanophenoxy)cyclohexyl]pyrazolo[4,3-c]pyridin-3-yl]pyrazol-1-yl]propane-1,2-diol
CID 162773746
(2S)-3-[4-[6-(ethylamino)-1-[4-[(3-fluoro-4-methyl-2-pyridinyl)oxy]cyclohexyl]pyrazolo[4,3-c]pyridin-3-yl]pyrazol-1-yl]propane-1,2-diol
CID 138715423
(2R)-3-[4-[6-(methylamino)-1-[4-[[2-(trifluoromethyl)-3-pyridinyl]oxy]cyclohexyl]pyrazolo[4,3-c]pyridin-3-yl]pyrazol-1-yl]propane-1,2-diol
CID 138715511
6-[4-[6-amino-3-(1-methylpyrazol-4-yl)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one
CID 138682923
6-[4-[6-(ethylamino)-3-[4-[(3-fluoroazetidin-1-yl)methyl]phenyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one
CID 138715032
(2R)-3-[4-[6-(ethylamino)-1-[4-[2-(trifluoromethyl)pyrimidin-4-yl]oxycyclohexyl]pyrazolo[4,3-c]pyridin-3-yl]pyrazol-1-yl]propane-1,2-diol
CID 138715656
6-[4-[6-(ethylamino)-3-[4-[[(3R)-3-methoxypyrrolidin-1-yl]methyl]phenyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one
CID 138715022
6-[4-[3-[4-[[(3R,4R)-3,4-dimethoxypyrrolidin-1-yl]methyl]phenyl]-6-(ethylamino)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one
CID 138715128
3-[4-[6-(ethylamino)-3-(1-methylpyrazol-4-yl)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methyl-N-propan-2-ylbenzamide
CID 138715317

Frequently Asked Questions

What is the IUPAC name of (2R)-3-[4-[6-amino-1-[4-(2-fluorophenoxy)cyclohexyl]pyrazolo[4,3-c]pyridin-3-yl]pyrazol-1-yl]propane-1,2-diol;1-[4-(2,3-difluorophenoxy)cyclohexyl]-3-(1-methylpyrazol-4-yl)-N-phenylpyrazolo[4,3-c]pyridin-6-amine;N-ethyl-1-[4-(2-fluorophenoxy)cyclohexyl]-3-(4-methylimidazol-1-yl)pyrazolo[4,3-c]pyridin-6-amine;N-ethyl-1-[4-(2-fluorophenoxy)cyclohexyl]-3-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrazolo[4,3-c]pyridin-6-amine;2-methyl-6-[4-[5-(methylamino)-1-(1-methylpyrazol-4-yl)pyrazolo[3,4-c]pyridin-3-yl]cyclohexyl]oxypyridazin-3-one?
The IUPAC name of (2R)-3-[4-[6-amino-1-[4-(2-fluorophenoxy)cyclohexyl]pyrazolo[4,3-c]pyridin-3-yl]pyrazol-1-yl]propane-1,2-diol;1-[4-(2,3-difluorophenoxy)cyclohexyl]-3-(1-methylpyrazol-4-yl)-N-phenylpyrazolo[4,3-c]pyridin-6-amine;N-ethyl-1-[4-(2-fluorophenoxy)cyclohexyl]-3-(4-methylimidazol-1-yl)pyrazolo[4,3-c]pyridin-6-amine;N-ethyl-1-[4-(2-fluorophenoxy)cyclohexyl]-3-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrazolo[4,3-c]pyridin-6-amine;2-methyl-6-[4-[5-(methylamino)-1-(1-methylpyrazol-4-yl)pyrazolo[3,4-c]pyridin-3-yl]cyclohexyl]oxypyridazin-3-one (CID 163419657) is (2R)-3-[4-[6-amino-1-[4-(2-fluorophenoxy)cyclohexyl]pyrazolo[4,3-c]pyridin-3-yl]pyrazol-1-yl]propane-1,2-diol;1-[4-(2,3-difluorophenoxy)cyclohexyl]-3-(1-methylpyrazol-4-yl)-N-phenylpyrazolo[4,3-c]pyridin-6-amine;N-ethyl-1-[4-(2-fluorophenoxy)cyclohexyl]-3-(4-methylimidazol-1-yl)pyrazolo[4,3-c]pyridin-6-amine;N-ethyl-1-[4-(2-fluorophenoxy)cyclohexyl]-3-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrazolo[4,3-c]pyridin-6-amine;2-methyl-6-[4-[5-(methylamino)-1-(1-methylpyrazol-4-yl)pyrazolo[3,4-c]pyridin-3-yl]cyclohexyl]oxypyridazin-3-one.
What is the SMILES notation for (2R)-3-[4-[6-amino-1-[4-(2-fluorophenoxy)cyclohexyl]pyrazolo[4,3-c]pyridin-3-yl]pyrazol-1-yl]propane-1,2-diol;1-[4-(2,3-difluorophenoxy)cyclohexyl]-3-(1-methylpyrazol-4-yl)-N-phenylpyrazolo[4,3-c]pyridin-6-amine;N-ethyl-1-[4-(2-fluorophenoxy)cyclohexyl]-3-(4-methylimidazol-1-yl)pyrazolo[4,3-c]pyridin-6-amine;N-ethyl-1-[4-(2-fluorophenoxy)cyclohexyl]-3-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrazolo[4,3-c]pyridin-6-amine;2-methyl-6-[4-[5-(methylamino)-1-(1-methylpyrazol-4-yl)pyrazolo[3,4-c]pyridin-3-yl]cyclohexyl]oxypyridazin-3-one?
The canonical SMILES for (2R)-3-[4-[6-amino-1-[4-(2-fluorophenoxy)cyclohexyl]pyrazolo[4,3-c]pyridin-3-yl]pyrazol-1-yl]propane-1,2-diol;1-[4-(2,3-difluorophenoxy)cyclohexyl]-3-(1-methylpyrazol-4-yl)-N-phenylpyrazolo[4,3-c]pyridin-6-amine;N-ethyl-1-[4-(2-fluorophenoxy)cyclohexyl]-3-(4-methylimidazol-1-yl)pyrazolo[4,3-c]pyridin-6-amine;N-ethyl-1-[4-(2-fluorophenoxy)cyclohexyl]-3-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrazolo[4,3-c]pyridin-6-amine;2-methyl-6-[4-[5-(methylamino)-1-(1-methylpyrazol-4-yl)pyrazolo[3,4-c]pyridin-3-yl]cyclohexyl]oxypyridazin-3-one is CCNc1cc2c(cn1)c(-c1ccc(CN3CCN(C)CC3)cc1)nn2C1CCC(Oc2ccccc2F)CC1.CCNc1cc2c(cn1)c(-n1cnc(C)c1)nn2C1CCC(Oc2ccccc2F)CC1.CNc1cc2c(C3CCC(Oc4ccc(=O)n(C)n4)CC3)nn(-c3cnn(C)c3)c2cn1.Cn1cc(-c2nn(C3CCC(Oc4cccc(F)c4F)CC3)c3cc(Nc4ccccc4)ncc23)cn1.Nc1cc2c(cn1)c(-c1cnn(C[C@@H](O)CO)c1)nn2C1CCC(Oc2ccccc2F)CC1.
What is the InChIKey of (2R)-3-[4-[6-amino-1-[4-(2-fluorophenoxy)cyclohexyl]pyrazolo[4,3-c]pyridin-3-yl]pyrazol-1-yl]propane-1,2-diol;1-[4-(2,3-difluorophenoxy)cyclohexyl]-3-(1-methylpyrazol-4-yl)-N-phenylpyrazolo[4,3-c]pyridin-6-amine;N-ethyl-1-[4-(2-fluorophenoxy)cyclohexyl]-3-(4-methylimidazol-1-yl)pyrazolo[4,3-c]pyridin-6-amine;N-ethyl-1-[4-(2-fluorophenoxy)cyclohexyl]-3-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrazolo[4,3-c]pyridin-6-amine;2-methyl-6-[4-[5-(methylamino)-1-(1-methylpyrazol-4-yl)pyrazolo[3,4-c]pyridin-3-yl]cyclohexyl]oxypyridazin-3-one?
The InChIKey is AHIYLGOZTPOIAW-REQHRXTNSA-N. The full InChI is InChI=1S/C32H39FN6O.C28H26F2N6O.C24H27FN6O3.C24H27FN6O.C22H26N8O2/c1-3-34-31-20-29-27(21-35-31)32(24-10-8-23(9-11-24)22-38-18-16-37(2)17-19-38)36-39(29)25-12-14-26(15-13-25)40-30-7-5-4-6-28(30)33;1-35-17-18(15-32-35)28-22-16-31-26(33-19-6-3-2-4-7-19)14-24(22)36(34-28)20-10-12-21(13-11-20)37-25-9-5-8-23(29)27(25)30;25-20-3-1-2-4-22(20)34-18-7-5-16(6-8-18)31-21-9-23(26)27-11-19(21)24(29-31)15-10-28-30(12-15)13-17(33)14-32;1-3-26-23-12-21-19(13-27-23)24(30-14-16(2)28-15-30)29-31(21)17-8-10-18(11-9-17)32-22-7-5-4-6-20(22)25;1-23-19-10-17-18(12-24-19)30(15-11-25-28(2)13-15)27-22(17)14-4-6-16(7-5-14)32-20-8-9-21(31)29(3)26-20/h4-11,20-21,25-26H,3,12-19,22H2,1-2H3,(H,34,35);2-9,14-17,20-21H,10-13H2,1H3,(H,31,33);1-4,9-12,16-18,32-33H,5-8,13-14H2,(H2,26,27);4-7,12-15,17-18H,3,8-11H2,1-2H3,(H,26,27);8-14,16H,4-7H2,1-3H3,(H,23,24)/t;;16?,17-,18?;;/m..1../s1.
What are the key properties of (2R)-3-[4-[6-amino-1-[4-(2-fluorophenoxy)cyclohexyl]pyrazolo[4,3-c]pyridin-3-yl]pyrazol-1-yl]propane-1,2-diol;1-[4-(2,3-difluorophenoxy)cyclohexyl]-3-(1-methylpyrazol-4-yl)-N-phenylpyrazolo[4,3-c]pyridin-6-amine;N-ethyl-1-[4-(2-fluorophenoxy)cyclohexyl]-3-(4-methylimidazol-1-yl)pyrazolo[4,3-c]pyridin-6-amine;N-ethyl-1-[4-(2-fluorophenoxy)cyclohexyl]-3-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrazolo[4,3-c]pyridin-6-amine;2-methyl-6-[4-[5-(methylamino)-1-(1-methylpyrazol-4-yl)pyrazolo[3,4-c]pyridin-3-yl]cyclohexyl]oxypyridazin-3-one?
(2R)-3-[4-[6-amino-1-[4-(2-fluorophenoxy)cyclohexyl]pyrazolo[4,3-c]pyridin-3-yl]pyrazol-1-yl]propane-1,2-diol;1-[4-(2,3-difluorophenoxy)cyclohexyl]-3-(1-methylpyrazol-4-yl)-N-phenylpyrazolo[4,3-c]pyridin-6-amine;N-ethyl-1-[4-(2-fluorophenoxy)cyclohexyl]-3-(4-methylimidazol-1-yl)pyrazolo[4,3-c]pyridin-6-amine;N-ethyl-1-[4-(2-fluorophenoxy)cyclohexyl]-3-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrazolo[4,3-c]pyridin-6-amine;2-methyl-6-[4-[5-(methylamino)-1-(1-methylpyrazol-4-yl)pyrazolo[3,4-c]pyridin-3-yl]cyclohexyl]oxypyridazin-3-one has a molecular weight of 2378.80 g/mol, XLogP of 22.78, 32 rotatable bonds, 7 hydrogen bond donors, and 40 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-3-[4-[6-amino-1-[4-(2-fluorophenoxy)cyclohexyl]pyrazolo[4,3-c]pyridin-3-yl]pyrazol-1-yl]propane-1,2-diol;1-[4-(2,3-difluorophenoxy)cyclohexyl]-3-(1-methylpyrazol-4-yl)-N-phenylpyrazolo[4,3-c]pyridin-6-amine;N-ethyl-1-[4-(2-fluorophenoxy)cyclohexyl]-3-(4-methylimidazol-1-yl)pyrazolo[4,3-c]pyridin-6-amine;N-ethyl-1-[4-(2-fluorophenoxy)cyclohexyl]-3-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrazolo[4,3-c]pyridin-6-amine;2-methyl-6-[4-[5-(methylamino)-1-(1-methylpyrazol-4-yl)pyrazolo[3,4-c]pyridin-3-yl]cyclohexyl]oxypyridazin-3-one is sourced from PubChem (CID 163419657), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).